vs
Andersons, Inc.（ANDE）与LifeStance Health Group, Inc.（LFST）财务数据对比。点击上方公司名可切换其他公司
LifeStance Health Group, Inc.的季度营收约是Andersons, Inc.的1.2倍（$382.2M vs $329.5M），Andersons, Inc.净利率更高（20.5% vs 3.1%，领先17.4%），LifeStance Health Group, Inc.同比增速更快（17.4% vs -2.4%），LifeStance Health Group, Inc.自由现金流更多（$46.6M vs $-77.1M），过去两年LifeStance Health Group, Inc.的营收复合增速更高（12.8% vs -1.8%）
安德森公司（The Andersons, Inc.）是1947年成立的美国农业企业，总部位于俄亥俄州莫米。公司起源于1940年代服务粮食行业的安德森货运站，是深耕农业领域的多元化企业，业务覆盖大宗商品贸易、可再生能源以及植物营养板块。
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
ANDE vs LFST — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $329.5M | $382.2M |
| 净利润 | $67.4M | $11.7M |
| 毛利率 | 70.3% | — |
| 营业利润率 | 26.6% | 4.7% |
| 净利率 | 20.5% | 3.1% |
| 营收同比 | -2.4% | 17.4% |
| 净利润同比 | 49.6% | 264.1% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $329.5M | $382.2M | ||
| Q3 25 | $295.8M | $363.8M | ||
| Q2 25 | $535.0M | $345.3M | ||
| Q1 25 | $370.8M | $333.0M | ||
| Q4 24 | $337.5M | $325.5M | ||
| Q3 24 | $231.9M | $312.7M | ||
| Q2 24 | $492.5M | $312.3M | ||
| Q1 24 | $341.4M | $300.4M |
| Q4 25 | $67.4M | $11.7M | ||
| Q3 25 | $20.1M | $1.1M | ||
| Q2 25 | $7.9M | $-3.8M | ||
| Q1 25 | $284.0K | $709.0K | ||
| Q4 24 | $45.1M | $-7.1M | ||
| Q3 24 | $27.4M | $-6.0M | ||
| Q2 24 | $36.0M | $-23.3M | ||
| Q1 24 | $5.6M | $-21.1M |
| Q4 25 | 70.3% | — | ||
| Q3 25 | 57.8% | — | ||
| Q2 25 | 29.6% | — | ||
| Q1 25 | 41.2% | — | ||
| Q4 24 | 63.1% | — | ||
| Q3 24 | 76.4% | — | ||
| Q2 24 | 35.6% | — | ||
| Q1 24 | 37.6% | — |
| Q4 25 | 26.6% | 4.7% | ||
| Q3 25 | 8.7% | 2.0% | ||
| Q2 25 | 4.6% | -0.9% | ||
| Q1 25 | 0.9% | 0.5% | ||
| Q4 24 | 19.9% | 0.3% | ||
| Q3 24 | 26.8% | 0.0% | ||
| Q2 24 | 11.6% | -5.1% | ||
| Q1 24 | 4.1% | -5.6% |
| Q4 25 | 20.5% | 3.1% | ||
| Q3 25 | 6.8% | 0.3% | ||
| Q2 25 | 1.5% | -1.1% | ||
| Q1 25 | 0.1% | 0.2% | ||
| Q4 24 | 13.4% | -2.2% | ||
| Q3 24 | 11.8% | -1.9% | ||
| Q2 24 | 7.3% | -7.5% | ||
| Q1 24 | 1.6% | -7.0% |
| Q4 25 | — | — | ||
| Q3 25 | $0.59 | — | ||
| Q2 25 | $0.23 | — | ||
| Q1 25 | $0.01 | — | ||
| Q4 24 | $1.31 | — | ||
| Q3 24 | $0.80 | — | ||
| Q2 24 | $1.05 | — | ||
| Q1 24 | $0.16 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $98.3M | $248.6M |
| 总债务越低越好 | $560.0M | $282.8M |
| 股东权益账面价值 | $1.2B | $1.5B |
| 总资产 | $3.7B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.45× | 0.19× |
8季度趋势，按日历期对齐
| Q4 25 | $98.3M | $248.6M | ||
| Q3 25 | — | $203.9M | ||
| Q2 25 | — | $188.9M | ||
| Q1 25 | — | $134.3M | ||
| Q4 24 | $561.8M | $154.6M | ||
| Q3 24 | — | $102.6M | ||
| Q2 24 | — | $87.0M | ||
| Q1 24 | — | $49.5M |
| Q4 25 | $560.0M | $282.8M | ||
| Q3 25 | — | $284.6M | ||
| Q2 25 | — | $286.4M | ||
| Q1 25 | — | $288.2M | ||
| Q4 24 | $608.2M | $290.0M | ||
| Q3 24 | — | $287.3M | ||
| Q2 24 | — | $288.0M | ||
| Q1 24 | — | $288.8M |
| Q4 25 | $1.2B | $1.5B | ||
| Q3 25 | $1.2B | $1.5B | ||
| Q2 25 | $1.4B | $1.5B | ||
| Q1 25 | $1.4B | $1.5B | ||
| Q4 24 | $1.4B | $1.4B | ||
| Q3 24 | $1.3B | $1.4B | ||
| Q2 24 | $1.3B | $1.4B | ||
| Q1 24 | $1.3B | $1.4B |
| Q4 25 | $3.7B | $2.2B | ||
| Q3 25 | $3.3B | $2.1B | ||
| Q2 25 | $3.4B | $2.1B | ||
| Q1 25 | $3.8B | $2.1B | ||
| Q4 24 | $4.1B | $2.1B | ||
| Q3 24 | $3.4B | $2.1B | ||
| Q2 24 | $3.3B | $2.1B | ||
| Q1 24 | $3.3B | $2.1B |
| Q4 25 | 0.45× | 0.19× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | 0.45× | 0.20× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.2M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | $-77.1M | $46.6M |
| 自由现金流率自由现金流/营收 | -23.4% | 12.2% |
| 资本支出强度资本支出/营收 | 21.5% | 2.9% |
| 现金转化率经营现金流/净利润 | -0.09× | 4.93× |
| 过去12个月自由现金流最近4个季度 | $-56.1M | $110.0M |
8季度趋势，按日历期对齐
| Q4 25 | $-6.2M | $57.6M | ||
| Q3 25 | $233.9M | $27.3M | ||
| Q2 25 | $299.3M | $64.4M | ||
| Q1 25 | $-350.0M | $-3.1M | ||
| Q4 24 | $268.8M | $62.3M | ||
| Q3 24 | $-2.1M | $22.7M | ||
| Q2 24 | $304.4M | $44.1M | ||
| Q1 24 | $-239.6M | $-21.8M |
| Q4 25 | $-77.1M | $46.6M | ||
| Q3 25 | $167.0M | $17.0M | ||
| Q2 25 | $250.5M | $56.6M | ||
| Q1 25 | $-396.6M | $-10.3M | ||
| Q4 24 | $212.9M | $56.0M | ||
| Q3 24 | $-40.0M | $17.7M | ||
| Q2 24 | $275.8M | $39.0M | ||
| Q1 24 | $-266.4M | $-26.9M |
| Q4 25 | -23.4% | 12.2% | ||
| Q3 25 | 56.5% | 4.7% | ||
| Q2 25 | 46.8% | 16.4% | ||
| Q1 25 | -106.9% | -3.1% | ||
| Q4 24 | 63.1% | 17.2% | ||
| Q3 24 | -17.2% | 5.7% | ||
| Q2 24 | 56.0% | 12.5% | ||
| Q1 24 | -78.0% | -9.0% |
| Q4 25 | 21.5% | 2.9% | ||
| Q3 25 | 22.6% | 2.8% | ||
| Q2 25 | 9.1% | 2.2% | ||
| Q1 25 | 12.6% | 2.2% | ||
| Q4 24 | 16.6% | 1.9% | ||
| Q3 24 | 16.3% | 1.6% | ||
| Q2 24 | 5.8% | 1.6% | ||
| Q1 24 | 7.8% | 1.7% |
| Q4 25 | -0.09× | 4.93× | ||
| Q3 25 | 11.61× | 25.34× | ||
| Q2 25 | 38.10× | — | ||
| Q1 25 | -1232.46× | -4.36× | ||
| Q4 24 | 5.96× | — | ||
| Q3 24 | -0.08× | — | ||
| Q2 24 | 8.46× | — | ||
| Q1 24 | -42.94× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANDE
| Specialty And Primary Nutrients | $137.1M | 42% |
| Premium Ingredients | $66.1M | 20% |
| Segment Reporting Reconciling Item Other | $63.2M | 19% |
| Other | $63.1M | 19% |
LFST
暂无分部数据
